Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Y-S Yap"'
Autor:
K S Lee, Y P Tan, L H Nguyen, R P Budoyo, K H Park, C Hufnagel, Y S Yap, N Møbjerg, V Vedral, T Paterek, R Dumke
Publikováno v:
New Journal of Physics, Vol 24, Iss 12, p 123024 (2022)
Quantum and biological systems are seldom discussed together as they seemingly demand opposing conditions. Life is complex, ‘hot and wet’ whereas quantum objects are small, cold and well controlled. Here, we overcome this barrier with a tardigrad
Externí odkaz:
https://doaj.org/article/c089d96d0e504029ab51e73d57749f26
Autor:
S. A. M. Gernaat, P. J. Ho, N. Rijnberg, S. C. Lee, S. H. Lim, Y. S. Yap, D. E. Grobbee, M. Hartman, H. M. Verkooijen
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Abstract Breast cancer incidence and survival is high in Southeast Asia. As such, many women diagnosed with breast cancer are at risk of dying of other causes. Given the increased risk of cardiotoxicity induced by breast cancer treatments, it is impo
Externí odkaz:
https://doaj.org/article/92d603e813fc41ce82679849aaba7ae6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Y-S Yap, Komal Jhaveri, Gary A. Ulaner, C Terret, Dejan Juric, N Kundamal, Shunji Takahashi, Adam S. Crystal, D Baldoni, Sara Cresta, François Duhoux, Serena Liao, Giuseppe Curigliano
Publikováno v:
Cancer Research. 79:PD1-08
Background: LSZ102 is an orally bioavailable SERD that inhibits ER gene transcription, induces receptor degradation, and blocks ER-dependent cell growth in preclinical models. This study is evaluating LSZ102 as a single agent and in combination with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f95b26e6efbb76e110953c3d1bce9f2
https://doi.org/10.1158/1538-7445.sabcs18-pd1-08
https://doi.org/10.1158/1538-7445.sabcs18-pd1-08
Autor:
Francisco J. Esteva, Andrew T. Chan, O Kong, Paul Wheatley-Price, Arnd Nusch, Y-S Yap, DJ Slamon, H. A. Burris, K Rodriguez Lorenc, D. A. Yardley, A Gaur, I Diaz-Padilla, Thomas Bachelot, Gabe S. Sonke
Publikováno v:
Cancer Research. 79:P6-18
Background: Patients (pts) with advanced breast cancer (ABC) who present with visceral metastases (mets) have a poorer prognosis vs pts with non-visceral disease. In the Phase III MONALEESA (ML) trials, ribociclib (RIB) + endocrine therapy (ET) prolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c48b2b80403c4298f7e499fcb2fd7fb
https://doi.org/10.1158/1538-7445.sabcs18-p6-18-07
https://doi.org/10.1158/1538-7445.sabcs18-p6-18-07
Autor:
A C, Tan, T J Y, Tan, S P L, Saw, J Y C, Lam, Y S, Yap, W-T, Lim, D W M, Tai, M C H, Ng, D S W, Tan
Publikováno v:
ESMO Open. 7:100537
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb61fa44584b898fbc317dca487906d
https://doi.org/10.1016/j.esmoop.2022.100537
https://doi.org/10.1016/j.esmoop.2022.100537
Autor:
Arunava Chakravartty, P. Serra, Salomon M. Stemmer, Gabriel N. Hortobagyi, M. Campone, Tanya Taran, Pierfranco Conte, CL Arteaga, F. Le Gac, Gabe S. Sonke, F Andre, Juan Pablo Zarate, Lowell L. Hart, Y-S Yap, Wolfgang Janni, EP Winer, K. Petrakova, Joyce A. O'Shaughnessy, David Cameron, H. A. Burris
Publikováno v:
Annals of Oncology. 32:S1290-S1291
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a2a1c71e8080096dfaf530d85c6fd72
https://doi.org/10.1016/j.annonc.2021.08.2090
https://doi.org/10.1016/j.annonc.2021.08.2090
Autor:
Z. Shen, B H Xu, Kenichi Inoue, L Yen-Shen, T Miyaki, Bo Zhang, Y Rai, H. Iwata, Noboru Yamamoto, Joanne Wing Yan Chiu, Y-S. Yap, Q Sun, Noriyuki Masuda, Mina Takahashi, Shoichiro Ohtani, Andrew T. Chan, S-B Kim, Richard Bryce, AZ Bustam, Jr Lee, Takashi Fujita
Publikováno v:
Cancer Research. 78:P1-13
Background: Current breast cancer knowledge is based largely on studies conducted in western populations. Their findings may not be generalizable to Asian women because of ethnic, genetic and lifestyle differences. Neratinib (N) is an irreversible ty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dc87f297fec9a09d3db421b1f3ea74d
https://doi.org/10.1158/1538-7445.sabcs17-p1-13-11
https://doi.org/10.1158/1538-7445.sabcs17-p1-13-11
Autor:
Y-S Yap, Sara Cresta, C Terret, Dejan Juric, Adam S. Crystal, François Duhoux, Komal Jhaveri, N Kundamal, Giuseppe Curigliano, S Bhansali, Serena Liao, Shunji Takahashi
Publikováno v:
Cancer Research. 78:P5-21
Background: LSZ102 is an orally bioavailable selective estrogen receptor degrader (SERD) that inhibits estrogen receptor (ER) gene transcription, induces receptor degradation, and blocks ER-dependent cell growth in preclinical models. This Phase I/Ib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af2f0d91de237882c6bc3d0c94cea428
https://doi.org/10.1158/1538-7445.sabcs17-p5-21-04
https://doi.org/10.1158/1538-7445.sabcs17-p5-21-04